Jose Trinidad Contreras, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Johanna Garcia Pena, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 613 W Sesame Dr, Harlingen, TX 78550 Phone: 956-399-4500 Fax: 956-399-4505 |
Ruby Ann Eldar, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1906 E Tyler Ave Ste G, Harlingen, TX 78550 Phone: 956-425-0606 Fax: 956-425-0620 |
Diana Torres, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Rodolfo Rodriguez, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1706 Treasure Hills Blvd, Harlingen, TX 78550 Phone: 956-365-6000 |
Eduardo Javier Pena, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Melissa Vega, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Maricela Cardoza, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 1122 Morgan Blvd, Harlingen, TX 78550 Phone: 956-427-8037 Fax: 956-427-8107 |
Kimberly Dianne Jennell, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Sylvia Margarita Espinosa, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Gina T Gutierrez, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 613 W Sesame Dr, Harlingen, TX 78550 Phone: 956-399-4500 Fax: 956-399-4505 |
Ruby Bueno Juarez, RN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Robert Jacob Kepperling, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Kristen Lauren Ramirez, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Sheila Rae Cantu, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Luis Gerardo Noriega, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Luis Antonio De Leon, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Natalia Rodriguez, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Reynaldo Cleto, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
Jennifer Gonzales, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 2102 W Teege Ave, Harlingen, TX 78550 Phone: 956-412-3337 |
News Archive
Personalized chemotherapy for rectal cancer results in high rates of pathologic response, indicate the results of a pilot study.
A Loyola University Medical Center study suggests that a procedure to treat acid reflux could help prevent chronic rejection in lung transplant patients.
Genzyme Corporation announced today that it has adopted new annual and long-term incentive plans for senior executives that will be utilized beginning in 2010.
Advanced metastatic melanoma is a disease that has proven difficult to eradicate. Despite the success of melanoma-targeting drugs, tumors inevitably become drug resistant and return, more aggressive than before. In the current issue of the journal Cancer Cell, however, researchers at The Wistar Institute describe how they increase the effectiveness of anti-melanoma drugs by combining anticancer therapies with diabetes drugs.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
› Verified 5 days ago